BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 12324733)

  • 1. Long-term administration of nicorandil abolishes ischemic and pharmacologic preconditioning of the human myocardium: role of mitochondrial adenosine triphosphate-dependent potassium channels.
    Loubani M; Galiñanes M
    J Thorac Cardiovasc Surg; 2002 Oct; 124(4):750-7. PubMed ID: 12324733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha1-Adrenoceptors during simulated ischemia and reoxygenation of the human myocardium: effect of the dose and time of administration.
    Loubani M; Galiñanes M
    J Thorac Cardiovasc Surg; 2001 Jul; 122(1):103-12. PubMed ID: 11436042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective mitochondrial adenosine triphosphate-sensitive potassium channel activation is sufficient to precondition human myocardium.
    Pomerantz BJ; Robinson TN; Morrell TD; Heimbach JK; Banerjee A; Harken AH
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):387-92. PubMed ID: 10917958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium.
    Hassouna A; Loubani M; Matata BM; Fowler A; Standen NB; Galiñanes M
    Cardiovasc Res; 2006 Feb; 69(2):450-8. PubMed ID: 16330008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass.
    Ghosh S; Galiñanes M
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):133-42. PubMed ID: 12878948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aging human myocardium: tolerance to ischemia and responsiveness to ischemic preconditioning.
    Loubani M; Ghosh S; Galiñanes M
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):143-7. PubMed ID: 12878949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle.
    Carr CS; Yellon DM
    Basic Res Cardiol; 1997 Aug; 92(4):252-60. PubMed ID: 9342432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels or Na/H exchange inhibition: which is the best protective strategy for heart transplants?
    Kevelaitis E; Oubénaissa A; Mouas C; Peynet J; Menasché P
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):155-62. PubMed ID: 11135172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the protective effects of a highly selective ATP-sensitive potassium channel opener and ischemic preconditioning in isolated human atrial muscle.
    Carr CS; Grover GJ; Pugsley WB; Yellon DM
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):473-8. PubMed ID: 9310276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine preconditioning of human myocardium is dependent upon the ATP-sensitive K+ channel.
    Cleveland JC; Meldrum DR; Rowland RT; Banerjee A; Harken AH
    J Mol Cell Cardiol; 1997 Jan; 29(1):175-82. PubMed ID: 9040032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKC-epsilon is upstream and PKC-alpha is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium.
    Hassouna A; Matata BM; Galiñanes M
    Am J Physiol Cell Physiol; 2004 Nov; 287(5):C1418-25. PubMed ID: 15294852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological and ischemic preconditioning of the human myocardium: mitoK(ATP) channels are upstream and p38MAPK is downstream of PKC.
    Loubani M; Galiñanes M
    BMC Physiol; 2002 Jul; 2():10. PubMed ID: 12123527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for mitochondrial K ATP channels as effectors of human myocardial preconditioning.
    Ghosh S; Standen NB; Galiñanes M
    Cardiovasc Res; 2000 Mar; 45(4):934-40. PubMed ID: 10728419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to precondition pathological human myocardium.
    Ghosh S; Standen NB; Galiñianes M
    J Am Coll Cardiol; 2001 Mar; 37(3):711-8. PubMed ID: 11693741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of human myocardium by bone marrow cells: role of long-term administration of the mitochondrial K(ATP) channel opener nicorandil.
    Lai VK; Galiñanes M
    J Surg Res; 2011 Nov; 171(1):66-70. PubMed ID: 20400115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals.
    Pain T; Yang XM; Critz SD; Yue Y; Nakano A; Liu GS; Heusch G; Cohen MV; Downey JM
    Circ Res; 2000 Sep; 87(6):460-6. PubMed ID: 10988237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated pharmacological preconditioning in combination with adenosine, a mitochondrial KATP channel opener and a nitric oxide donor.
    Uchiyama Y; Otani H; Okada T; Uchiyama T; Ninomiya H; Kido M; Imamura H; Nakao S; Shingu K
    J Thorac Cardiovasc Surg; 2003 Jul; 126(1):148-59. PubMed ID: 12878950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preconditioning by mitochondrial ATP-sensitive potassium channel openers: An effective approach for improving the preservation of heart transplants.
    Kevelaitis E; Oubénaïssa A; Peynet J; Mouas C; Menasché P
    Circulation; 1999 Nov; 100(19 Suppl):II345-50. PubMed ID: 10567327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective mitochondrial KATP channel opening controls human myocardial preconditioning: too much of a good thing?
    Pomerantz BJ; Robinson TN; Heimbach JK; Calkins CM; Miller SA; Banerjee A; Harken AH
    Surgery; 2000 Aug; 128(2):368-73. PubMed ID: 10923018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preconditioning blocks cardiocyte apoptosis: role of K(ATP) channels and PKC-epsilon.
    Liu H; Zhang HY; Zhu X; Shao Z; Yao Z
    Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1380-6. PubMed ID: 11893574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.